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Abstract
Background: Testosterone (T) and the sympathetic nervous system each contribute to the pathology of
hypertension. Altered blood vessel reactivity is also associated with the pathology of high blood pressure. The
purpose of this study was to examine the effects of T manipulation in the regulation of resistance-sized blood
vessel reactivity.
Methods: Adult spontaneously hypertensive (SHR) and Wistar Kyoto (WKY) male rats at 8 weeks of age were used.
The rats were divided into groups consisting of gonadally intact controls (CONT), castrate with sham implant
(CAST) and castrate with T implant (CAST + T) (n = 6 to 12 per group). Following a short-term period of T
treatment (approximately 4 weeks), plasma norepinephrine (NE) and plasma T were assessed by performing high-
performance liquid chromatography and RIA, respectively. Resistance-sized mesenteric artery reactivity was assessed
on a pressurized arteriograph for myogenic reactivity (MYO), phenylephrine (PE) responsiveness and passive
structural mechanics.
Results: SHR and WKY males exhibited similar physiological trends in T manipulation, with castration significantly
lowering plasma T and NE and T replacement significantly increasing plasma T and NE. T manipulation in general
resulted in significant alterations in MYO of second-order mesenteric arteries, with T replacement decreasing MYO
in SHR (P < 0.05) compared to CONT, T replacement increasing MYO, and CAST decreasing MYO in WKY rats (P <
0.001) compared to CONT rats. Additionally, PE-induced constriction was significantly altered in both strains
following T treatment, with the effective concentration of PE to constrict the vessel to 50% of the total diameter
significantly increased in the CAST + T SHR compared to CONT (P < 0.05). Comparisons of passive structural
mechanics between SHR and WKY treatment groups indicated in SHR a significantly increased wall-to-lumen ratio
and decreased circumferential wall stress compared to WKY treatment groups.
Conclusions: These data suggest that T and NE are involved in a complex interaction with both myogenic
reactivity and structural alterations of resistance-sized blood vessels and that these factors likely contribute to the
development and maintenance of hypertension.
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Studies of the etiology of hypertension have shown signifi-
cant gender differences in the incidence of cardiovascular
disease and related pathology [1]. These differences likely
involve the sex hormones, particularly testosterone (T),
which contributes to the various mechanisms involved
with the development of hypertension. In addition, T (and
related sex steroids) plays an integral role in hemodynamic
forces, humoral interactions and the sympathetic nervous
system, all of which are clearly important in cardiovascular
system regulation [2]. The role of sex hormones in cardio-
vascular diseases is well-documented, with research
widening in scope to include how various molecular and
genetic signaling pathways alter vascular function [2]. Spe-
cifically, vascular function is increasingly being examined
in a variety of specific in vitro models of isolated resis-
tance-sized vessels, in which, following direct or indirect
treatment of the vessel, T has been implicated in the
pathogenesis of hypertension [3,4].
An established model of hypertension commonly stu-
died is the spontaneously hypertensive rat (SHR), often
compared to the normotensive Wistar Kyoto (WKY) rat.
Strong support for potential detrimental effects of T and
the protective effects of estrogen on cardiovascular func-
tion [5-7] has been demonstrated in this animal model.
We have shown that prepubertal CAST lowers blood pres-
sure in the SHR model, with T replacement restoring and
even elevating blood pressure beyond gonadally intact
levels [7]. These studies suggest that hypertension in SHR
is a result of genetic and environmental interactions that
can lead to cardiovascular pathology [2]. These data also
clearly suggest an integral role of T in the regulation of
blood pressure in male animals.
Reckelhoff and Granger demonstrated the role of the
androgen receptor (AR) in the regulation of blood pres-
sure [8]. Our group has shown that T and the AR in asso-
ciation with the SHR Y chromosome are necessary for
sympathetic nervous system potentiation of blood pressure
[7]. Furthermore, we have demonstrated the importance of
T and the AR in the regulation of mesenteric artery reac-
tivity in an animal model of AR deficiency (testicular fem-
inized male) where myogenic reactivity (MYO) increased
along with phenylephrine (PE) sensitivity following in vivo
T treatment [9]. However, the role of T following in vivo
manipulation in the regulation of resistance-sized mesen-
teric arteries during genetic hypertension remains unclear.
As a result, the overall objective of this study was to
investigate the effects of in vivo T manipulation on iso-
lated resistance-sized mesenteric artery vascular behavior.
To pursue this objective, MYO, adrenergic vasoconstric-
tion (by PE) and passive structural mechanics were exam-
ined. Therefore, the hypotheses for this investigation were
that in vivo T manipulation will show (1) increased MYO
in WKY compared to SHR males, (2) decreased adrenergic
sensitivity in SHR compared to WKY males and (3) differ-
ential alteration in structural and mechanical vessel para-
meters in SHR and WKY males.
Methods
Animal model
SHR/Hsd and WKY/Hsd rats were originally obtained
from Harlan Sprague-Dawley (Indianapolis, IN, USA), and
colonies have been maintained at the University of Akron
research facility since 1981 (SHR and WKY). All animals
used in this study were from the University of Akron
colony.
The overall study utilized a two-strain by three-treat-
ment design with SHR and WKY male rats. The treat-
ments were administered to gonadally intact controls
(CONT), castrate with sham implant (CAST) and castrate
with testosterone implant (CAST + T) animals, with 6 to
12 rats in each group. All protocols were reviewed and
approved by the University of Akron’s Institutional Animal
Care and Use Committee.
All animals were pair-housed by strain and were sub-
jected to a 12-hour:12-hour light-dark cycle and main-
tained on a normal sodium diet (0.3% Na, Prolab 3000 Rat
Chow; PMI Feeds, St Louis, MO, USA). Food and water
were accessible ad libitum.
Testosterone manipulation
Gonadectomy
Eight-week-old male rats were sedated with 2.5% sodium
pentothal (50 mg/kg intraperitoneally; Eli Lilly & Co.,
Indianapolis, IN, USA), and both testes were removed. In
a similar manner, male rats to be T-implanted were
castrated and the implant was inserted beneath the skin,
between the shoulder blades and parallel to the longitudi-
nal axis of the rat. Implants were replaced biweekly over
the study duration of 4 weeks [10], with all animals being
approximately 12 weeks of age when killed.
Testosterone implants
T implants were prepared by packing Silastic tubing (inner
diameter = 1.57 mm, outer diameter = 3.17 mm) with 19
mm of testosterone propionate (Sigma-Aldrich, St Louis,
MO, USA) as previously described [10]. Previous studies
conducted in our laboratory [5,10,11] indicated that this
level of T, although high, shows consistent results in influ-
encing systolic blood pressure: WKY CONT (112 mmHg),
WKY CAST (108 mmHg), WKY CAST + T (124 mmHg),
SHR CONT (158 mmHg), SHR CAST (126 mmHg) and
S H RC A S T+T( 1 8 5m m H g ) .T h i sp r o d u c e sTl e v e l s
higher than normal, but we maintain that they are not out
of physiological range for high normal physiological func-
tion. For instance, Toot et al. [10] showed that the same T
implant used in this study restored sodium and potassium
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WKY and SHR hybrid animals. The plasma T after the
implant was about the same as in the present study. CAST
lowered blood pressure in both strains, and T restored the
blood pressure. Plasma aldosterone followed likewise: It
was increased by CAST and restored by T, suggesting that
the level of T, although high, was not too high and
returned electrolytes to homeostasis. Also, Sharma et al.
[11] showed a similar blood pressure response to CAST
and T replacement. They found a highly significant corre-
lation (r = 0.8) between plasma T and blood pressure.
Blood samples
Following the conclusion of the study, animals were
anesthetized with 2.5% sodium pentothal prior to being
killed. A 2- to 3-ml retroorbital blood sample [12] was
collected between 1,100 and 1,700 hours and centrifuged
for 15 minutes (5,000 × g) to obtain plasma for T and NE
analysis. T levels were analyzed in plasma by RIA (Bio-
Rad Laboratories, Hercules, CA, USA). The correlation
with another kit was r = 0.991, sensitivity was 0.08 ng/ml
at the 95% confidence limit and the highest cross-reactiv-
ity with potential interfering steroids was with 5a-dihy-
drotestosterone (DHT) (6.65%). The coefficient of
variation for our sample intrarun was 7.4% to 11.6%, and
for the interrun it was 12.5% to 16.96%.
Plasma NE was assayed by high-performance liquid
chromatography with electrochemical detection (Waters
460; Waters Corp, Milford, MA, USA) [13] as previously
described by investigators at our laboratory [14]. The
minimum sensitivity of the NE assay was 30 pg/ml.
Pressure arteriograph
Vessel isolation
After the rats were killed (overdose of 2.5% sodium pen-
tothal), their mesenteries were placed in an ice-cold 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-
buffered physiological saline solution as previously
described [4]. Second-order mesenteric arteries (250 to
350 μm in diameter) were isolated and mounted onto two
glass cannulae in a pressurized arteriograph (Living Sys-
tems Instrumentation, Burlington, VT, USA). After resi-
dual blood was removed from the vessel, the distal
cannula was occluded. The pressure arteriograph servo
controller was used to maintain constant pressure of 60
mmHg for a 45-minute equilibration. The arteries were
then conditioned to stretch by increasing pressure from 60
to 100 mmHg. The pressure was then returned to 60
mmHg and equilibrated for an additional 15 minutes.
Myogenic reactivity
By definition, MYO is the active response of an artery in
response to change in intraluminal pressure. This
response was investigated in an isobaric pressure arterio-
graph under a no-flow state. Following equilibration, the
vessel was preconstricted to 70% to 85% of the initial dia-
meter with PE (or about 25% constriction). This has pre-
viously been shown to optimize the myogenic response
and induce equivalent tone in all arteries [4]. The
selected intraluminal pressure was then changed in a
stepwise manner from 20 to 120 mmHg in increments of
20 mmHg every 5 minutes, with only the intraluminal
pressures from 60 to 120 mmHg being reported. Vessel
diameters were measured with an electronic filar micro-
scope (Lasico, Los Angeles, CA, USA). MYO was calcu-
lated as the percentage change in diameter in response to
changes in intraluminal pressure [4].
MYO for each vessel was compared as the percentage
change from the initial diameter at 20 mmHg as calculated
using the following equation: ((Dx - D20)/(D20)) × 100,
where Dx represents the diameter at a specific transmural
pressure and D20 is the luminal diameter at 20 mmHg. A
positive percentage change indicated by this equation is
representative of dilation, whereas a negative percentage
change is representative of constriction. Increases in MYO
can be determined by a small positive or negative percen-
tage change from the initial diameter [4]. Diameters
reported in this study are for changes from 60 to 120
mmHg in the intraluminal diameter.
Phenylephrine constriction
A subset of resistance-sized mesenteric arteries was used
to study PE constriction response. The a-adrenergic ago-
nist PE was administered at the following cumulative
concentrations of 0.1 to 7.0 μM/L. After initial diameter
determination, mesenteric arteries were exposed to
increasing concentrations of PE with 4 minutes between
each administration to allow for a maximum response.
Changes in diameter at each PE concentration were com-
pared to the initial artery diameter as percentage con-
striction and then normalized as percentage maximum
constriction.
Passive structural mechanics
A separate set of resistance-sized mesenteric arteries
were analyzed under passive conditions to determine the
following structural characteristics: wall thickness, wall-
to-lumen ratios, wall stress and distensibility of resis-
tance-sized mesenteric arteries. The passive HEPES buf-
fer was made without calcium in the presence of 0.1 mM
ethylene glycol tetraacetic acid and 0.1 mM papaverine
to inactivate the smooth muscle of the vessel. A constant
pressure of 60 mmHg was held and the vessel was equili-
brated in this buffer for 30 minutes. The luminal dia-
meter and vessel wall diameter were measured with an
electronic filar and expressed in micrometers. Wall-to-
lumen ratios were calculated as follows: ω/Øinner,w h e r e
ω is the vessel wall thickness diameter and Øinner is the
luminal diameter. Wall stress was calculated using the
following equation (assuming the arterial wall to be uni-
form), assuming 1 mmHg = 1,333.2 dyn/cm
2:T / ω, where
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luminal radius and ω is the vessel wall thickness. All wall
stress values were multiplied by 10
5 to reduce scientific
notation. Arterial distensibility was calculated using the
following equation: ((Øx -Ø 0m m H g ) - 1) × 100. In this
equation, Øx is the luminal diameter at a specific intra-
luminal pressure and Ø0 mmHg is the luminal diameter at
0 mmHg and expressed as percentage distensibility [15].
Statistics
Data were analyzed using the Sigma version 9.1 statistical
software package (SigmaStat and SigmaPlot; SYSTAT
Software, Inc, San Jose, CA, USA) or JMP software (Cary,
NC, USA). One-way analysis of variance (ANOVA) was
used to analyze each variable by treatment, as well as
appropriate t-tests and regression analysis where applic-
able. Two-way ANOVA with repeated measures was used
where appropriate with T treatment (CONT, CAST and
CAST + T) and strain (SHR and WKY) as factors to deter-
mine the effect on plasma T and plasma NE. Statistical
analysis of mesenteric artery bioassays was performed
using two-way ANOVA and a post hoc Bonferroni test
with T treatment and intraluminal pressure or PE concen-
tration as factors. For MYO, only the intraluminal pres-
sures of 60 to 120 mmHg were used for the statistical
analyses. SigmaPlot software was used to calculate effec-
tive concentration needed to constrict to 50% of total dia-
meter (EC50) values from concentrations using standard
curve analysis. The EC50 values were analyzed using two-
way ANOVA. Statistical significance was identified at a
value of P < 0.05.
Results
Comparison of MYO of resistance-sized mesenteric
arteries from CONT, CAST and CAST + T animals within
the SHR strain (Figure 1A) demonstrated a significant
treatment effect (F = 6.6, P < 0.05) specifically a decrease
in MYO in SHR CAST + T males compared to SHR
CONT males (P < 0.05). The comparison of WKY (Figure
1B) MYO of resistance-sized mesenteric arteries demon-
strated a significant treatment effect (F = 6.2, P < 0.05).
Specifically, the WKY CAST + T males demonstrated an
increase in MYO of resistance-sized mesenteric arteries
compared to WKY CONT (P < 0.05).
Plasma T concentrations were similar in each of the
treatment groups, regardless of strain. In both SHR and
WKY rats, there was a significant treatment effect (F = 5.6,
P < 0.01) where the CAST group had the lowest plasma T
and the CAST + T group had the highest plasma T (Table
1). Within strains, CAST decreased plasma T from CONT
levels (P < 0.001) and CAST + T increased plasma T from
CONT levels (P < 0.001) in both SHR and WKY males. In
both SHR and WKY males. there was a significant NE
treatment effect (F = 16.9, P <0 . 0 0 1 ) .T h eS H RC O N T
males had a significantly higher plasma NE compared to
WKY CONT males (P < 0.001). No plasma NE strain dif-
ferences were found between CAST and CAST + T males.
In SHR, plasma NE decreased from control levels follow-
ing CAST (P < 0.01) and T replacement increased plasma
NE toward control levels (P < 0.05). Plasma NE followed a
similar trend in WKY T-manipulated rats but did not
achieve statistical significance.
Within the SHR strain, there was a significant treatment
effect (F = 4.5, P < 0.05) where the PE percentage maxi-
mum constriction (Figure 2A) for SHR CAST + T males
was significantly decreased compared to the SHR CONT
(P < 0.05) and SHR CAST groups (P < 0.05). Within the
WKY strain, there was a significant treatment effect (F =
6.9, P < 0.01) where PE percentage maximum constriction
(Figure 2B) for WKY CAST + T rats was significantly
increased compared to WKY CONT rats (P <0 . 0 5 ) .M a x i -
mal mean ± SEM contractile responses for PE were as fol-
lows: SHR CONT (60.1 ± 3.5%), SHR CAST (56.7 ± 3.9%),
SHR CAST + T (43.9 ± 6.1%), WKY CONT (70.7 ± 1.7%),
WKY CAST (62.0 ± 5.3%) and WKY CAST + T (66.8 ±
2.7%).
The EC50 levels for the second-order mesenteric
arteries are presented in Table 2. There was a significant
strain effect (F = 7.2, P < 0.05) and treatment effect (F =
3.8, P < 0.05). Within the SHR strain, the EC50 for SHR
CAST + T was significantly higher compared to SHR
CONT (P <0 . 0 1 ) .W i t h i nt h eW K Ys t r a i n ,W K YC O N T
was significantly higher compared to CAST (P < 0.05)
and CAST + T (P = 0.051).
Passive structural parameters (Table 3) were deter-
mined under passive conditio n s( w i t h o u tc a l c i u m )a ta
constant pressure of 60 mmHg. No differences in passive
inner luminal diameter were found within the SHR strain
or the WKY strain. Between strains, however, the SHR
CAST + T passive diameter was significantly decreased
compared to WKY CAST + T (F = 7.2, P <0 . 0 5 ) .W a l l
thickness was unaltered within the SHR and WKY
strains. Comparisons between strains, however, demon-
strated a significantly thicker vessel wall between SHR
CONT and WKY CONT animals (F = 5.8, P < 0.05).
Wall-to-lumen ratios were unaltered within the SHR and
WKY strains, but SHR was significantly higher than
WKY in all treatment groups for wall-to-lumen ratios
(F = 6.9, P < 0.05).
Passive mechanical parameters (Table 4) were deter-
mined under passive conditions (without calcium) at a
constant pressure of 60 mmHg. Circumferential wall
stress demonstrated no differences within the SHR or
W K Ys t r a i n .H o w e v e r ,W K YC O N Th a das i g n i f i c a n t l y
higher wall stress than SHR CONT (F = 10.6, P <0 . 0 1 )
and WKY CAST and CAST + T were significantly
higher than SHR CAST (F = 5.1, P <0 . 0 5 )a n dC A S T+
T (F = 5.8, P < 0.05), respectively.
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Figure 1 Myogenic reactivity of resistance-sized mesenteric arteries from spontaneously hypertensive and Wistar Kyoto testosterone-
manipulated male rats. Myogenic reactivity is expressed as percentage change in diameter from an initial diameter at 20 mmHg. Only 60- to
120-mmHg pressure points are expressed in the graphs (means ± SEM). (A) Mesenteric arteries from spontaneously hypertensive control (SHR
CONT) males displayed increased myogenic reactivity compared to SHR castrate plus testosterone (CAST + T) (*P < 0.05). (B) Mesenteric arteries
from Wistar Kyoto (WKY) CAST + T rats displayed increased myogenic reactivity compared to WKY CONT rats (*P < 0.05).
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in the SHR and WKY T groups in calcium-free passive
buffer (Figure 3). Within the SHR strain, there was a
significant treatment effect (F = 8.3, P < 0.001), with
S H RC A S T+Tb e i n gs i g n i f i c a n t l yh i g h e rt h a nS H R
CONT (P < 0.05) and SHR CAST (P < 0.05) (Figure
3A). Within the WKY strain, there was a significant
treatment effect (F = 5.1, P < 0.05). Specifically, CAST
was significantly higher than CONT (P <0 . 0 5 )a n d
CAST + T (P < 0.05).
Discussion
The results of this study support our hypothesis that in
vivo manipulation of T resulted in altered regulation of
MYO, PE responsiveness and passive structural
mechanics from SHR and WKY males. The role of T
treatment has been shown to result in nitric oxide-
dependent vasodilation, vasodilation resulting from
blocking the endothelial calcium channel, vasoconstric-
tion through potassium channel activation, restoring
vasoreactivity in compromised vessels or having no clear
effect on vasoreactivity [16-18]. Human studies have
demonstrated that acute administration of T can
improve vascular reactivity and is associated with gen-
eral decreases in risk factors for cardiovascular patholo-
gies such as hypertension [19-22]. However, chronic T
treatment in humans can result in increased blood pres-
sure and risk factors for cardiovascular diseases [23-25].
Evidence reported in the literature remains inconclusive
regarding the specific molecular and/or direct effects of
T on the vasculature. The findings from this study mir-
ror those of the previously discussed human data in that
it has been demonstrated that T can act as a vasodilator,
possibly through a combination of both genomic and
nongenomic pathways [3,16,26-28]. Even with the rela-
tively large body of research involving vessel mechan-
isms, evidence of the effects of in vivo or whole animal
T treatment on vascular reactivity is currently lacking
[9,29].
The primary sites of peripheral vascular resistance are
the small arteries and arteriolar networks [30]. Isolated
resistance caliber mesenteric arteries are useful in iden-
tifying in vitro vessel reactivity and structural mechanics.
This study demonstrates that SHR and WKY males
treated with T in vivo have altered reactivity of resis-
tance-sized mesenteric arteries. The arteries from SHR
CAST + T males exhibited a significant decrease in
MYO compared to those taken from SHR CONT males
(P < 0.05). Within the WKY strain, mesenteric arteries
exhibited altered MYO following T manipulation, with
those taken from WKY CAST + T animals displaying
significant constriction in response to intraluminal pres-
sure increases compared to WKY CONT and CAST.
Incidentally, this increase in myogenic response in
arteries from the WKY CAST + T rats was significantly
different from that of arteries of SHR CAST + T ani-
mals. This might be a contributing factor to the higher
systemic blood pressure reported in WKY CAST + T
animals in our previous studies [5,10]. As T concentra-
tions were increased beyond gonadally intact levels, T in
combination with increased NE may have contributed to
the increased MYO of resistance-sized mesenteric
arteries in WKY CAST + T animals. Although NE levels
were not significantly different by treatment in WKY
animals, the trends were the same as in SHR, with some
T overshoot in WKY. However, just because WKY
plasma NE was not significant does not mean that it
could not have an effect on interaction with the vessel
wall through mechanisms described below involving a
T-NE interaction. For instance, in resistance-sized cere-
bral arteries, Geary and colleagues found that CAST +
T increased MYO of small middle cerebral arteries com-
pared to CONT [29]. These data, in combination with
those described in our previous reports [4,9], indicate a
possible contribution of T in the regulation of MYO in
resistance-sized mesenteric arteries. Additionally, the
concept of structural autoregulation provided by Folkow
[2] may play a mechanistic role in these data. The
increased wall thickness in SHR CAST + T animals may
require less MYO to decrease flow and may have an
appreciable effect on blood pressure, whereas WKY
CAST + T animals may require more MYO of mesen-
teric arteries to decrease flow and increase blood
pressure.
CAST can have many diverse physiological effects, and
one of them is reduced ARs in many tissues of the rat
[31], which can be restored by androgens [32,33].
Because many genes have androgen-responsive elements,
Table 1 SHR and WKY plasma testosterone and plasma norepinephrine levels by treatment group
a
Treatment Strain CONT CAST CAST + T
Testosterone (ng/ml) SHR 1.88 ± 0.52 0.05 ± 0.60 12.9 ± 0.70
WKY 1.08 ± 0.52 0.04 ± 0.70 11.0 ± 0.78
Norepinephrine (pg/ml) SHR 970.5 ± 88.4*** 481.5 ± 50.4** 762.2 ± 53.8*
WKY 569.5 ± 28.1 415.5 ± 97.3 644.9 ± 74.6
aCAST, castrate; CAST + T, castrate plus testosterone; CONT, control; NE, norepinephrine; SHR: spontaneously hypertensive rat; T: testosterone; WKY: Wistar Kyoto.
Data are means ± SEM. Plasma T was unaltered between SHR and WKY T-manipulated groups. Plasma NE was significantly higher in SHR CONT males than in
WKY CONT males (***P < 0.001). Plasma NE was decreased in SHR CAST compared to CONT (**P < 0.01) and increased compared to CAST + T (*P < 0.05).
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Figure 2 Phenylephrine (PE) induced vasoconstriction of resistance-sized mesenteric arteries from SHR and WKY testosterone-
manipulated males. Data are expressed as percentage maximum constriction (means ± SEM). (A) Mesenteric arteries from spontaneously
hypertensive castrate plus testosterone (SHR CAST + T) males demonstrated decreased phenylephrine (PE) constriction compared to SHR control
(SHR CONT) rats (*P < 0.05) and SHR CAST rats (
†P < 0.01). (B) Mesenteric arteries from WKY CAST + T males displayed increased PE constriction
compared to WKY CONT rats (*P < 0.05).
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pronounced effects on gene pathways. One of the com-
plicating factors in this study is the timing of the effects
of T removal and restoration. CAST was performed
when the rats were 8 weeks of age, and the T replace-
ment lasted 4 weeks, so it is difficult to speculate about
t h es p e c i f i ce f f e c to nA R s .W h a tw ed ok n o wi st h a t
CAST seems to downregulate ARs and that T replace-
ment appears to rapidly restore the ARs, so we assume
that the ARs were restored in the T replacement group,
but with the high dose of T, the exact effect is not
known.
Separately, there is a specific influence of CAST and T
restoration on adrenergic effectors. T has been reported to
increase the a1-adrenergic receptors in tail arteries,
whereas gonadectomy attenuates the total number of
binding sites in SHR [34]. Phillipe et al. [35] showed a
more than twofold increase in the a1-adrenergic receptors
in response to both T and DHT. Jones et al. [36] showed
that T restoration increased renal NE levels, which were
increased by more than 100% in the presence of T in male
SHR compared to no enhancement of renal NE release by
T in WKY [34]. Kumai et al. [37] showed that CAST
decreased the rate-limiting enzyme for the catecholamine
tyrosine hydroxylase (TH). Likewise, Lara et al. [38]
showed that CAST decreased the adrenergic receptor den-
sity, which was reversed with T, and they found that T
regulates the adrenergic receptor gene in the SHR at the
gene level [39].
Another effect is the interaction of T with adrenergic
pathways. T has been shown to modulate NE tissue sto-
rage and release [5,36]. There may also be a T interaction
with tissue NE which cannot be detected by plasma NE
measurements alone. Mayerhofer et al. [40] showed that
in the immature testis of the golden hamster, catechola-
mines acting through both a- and b-adrenergic receptors
may be potent physiological stimulators of T production.
Another potential T-NE interaction may occur through
enhanced sympathetic outflow, which can increase blood
pressure [14]. Sjöstrand and Swedin showed that andro-
gens have no substantial direct effect on adrenergic
innervation per se, but that they do affect the transmitter
levels of the male organs indirectly through changes in
the number, size and relative proportion of the target
cells of the adrenergic nerves, that is, the smooth muscle
cells [41]. Using males with defective ARs (testicular fem-
inized males), our research group found that CAST
decreased dopamine in several brain areas associated
with blood pressure control [42]. Specifically, blood pres-
sure correlated with dopamine levels in the medial amyg-
dala, frontal cortex and basal nucleus of the stria
terminalis. T and DHT influenced brain catecholamines
in testicular feminized mutation animals, which supports
the influence of a non-AR alternative mechanism. These
data demonstrate an action of androgen on brain cate-
cholamines and blood pressure that is independent of the
classic AR. In future studies, we will examine the specific
signaling mechanisms of T and DHT on both AR and
non-AR effects on central nervous system catechola-
mines and g-aminobutyric acid receptors.
Treatment of 40-day CAST rats with T restored not
only the wet weights of the internal sex organs to nor-
mal but also their NE content and dopamine-b-hydroxy-
lase activity [43]. Goldstein et al. showed that TH
activity and TH mRNA in sympathetic ganglia was
reduced after castration [44]. At the gene level, the AR
transactivates the TH promoter in a ligand-dependent
manner [45].
Table 2 Effective concentration needed to constrict to 50% of total diameter with phenylephrine in SHR and WKY
treatment groups
a
Treatment Strain CONT CAST CAST + T
EC50 SHR 830 ± 36 nM (n = 10) 827 ± 60 nM (n = 6) 1,570 ± 433 nM (n = 6)**
WKY 844 ± 45 nM (n = 10) 734 ± 66 nM (n = 6)* 740 ± 41 nM (n = 6)*
aCAST, castrate; CAST + T, castrate plus testosterone; CONT, control; EC50, effective concentration needed to constrict to 50% of total diameter; SHR,
spontaneously hypertensive rat; WKY: Wistar Kyoto. Data are means ± SEM. SHR CAST + T was significantly higher than SHR CONT (**P < 0.01). WKY CONT was
significantly higher than CAST (*P < 0.05).
Table 3 Passive structural parameters of the SHR and WKY treatment groups
a
Treatment Strain CONT CAST CAST + T
Passive diameter (μm) SHR 305.4 ± 22.9 (n = 9) 285.7 ± 14.5 (n = 12) ++274.3 ± 6.4 (n = 10)
WKY 352.8 ± 26.0 (n = 8) 301.9 ± 10.9 (n = 8) 309.6 ± 10.1 (n = 14)
Wall thickness (μm) SHR *34.9 ± 2.5 (n = 9) 28.4 ± 2.3 (n = 12) 31.7 ± 3.4 (n = 10)
WKY 24.1 ± 3.8 (n = 8) 22.2 ± 3.5 (n = 8) 23.9 ± 2.7 (n = 10)
Wall-to-lumen ratio SHR *0.117 ± 0.009 (n = 9) +0.102 ± 0.009 (n = 12) ++0.124 ± 0.014 (n = 10)
WKY 0.070 ± 0.001 (n = 8) 0.070 ± 0.010 (n = 8) 0.080 ± 0.010 (n = 12)
aCAST, castrate; CAST + T, castrate plus testosterone; CONT, control; SHR: spontaneously hypertensive rat; T: testosterone; WKY: Wistar Kyoto. Data are means ±
SEM. *P < 0.05 for SHR CONT vs WKY CONT. +
†P < 0.05 for SHR CAST vs WKY CAST.++
‡P < 0.05 for SHR CAST + T vs WKY CAST + T.
Toot et al. Biology of Sex Differences 2012, 3:1
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Page 8 of 13In summary, both T and adrenergic pathways have
pronounced effects on many tissues and at many organi-
zational levels (receptors, physiological pathways and
genes), which can all have a significant influence on the
resistance vasculature.
MYO is clearly a complex mechanism involving the
integration of all three vascular layers (endothelium,
smooth muscle and the extracellular matrix), as well as
the chronic effects of T and NE. Researchers in studies
who used isobaric vessel techniques have identified sev-
eral vascular strain differences between SHR and WKY
males. Specifically, SHR males have been shown to exhi-
bit altered MYO at given pressures [46]. Izzard and col-
leagues were able to demonstrate differences in myogenic
tone between SHR and WKY strains within the physiolo-
gical range of pressure at 5 weeks of age. They also
demonstrated, however, that myogenic tone generation is
similar over the physiological pressure range in SHR and
WKY rats at 20 weeks of age, suggesting that established
hypertension leads to normalization of the myogenic
response [46]. Research conducted at our laboratory has
demonstrated an earlier prepubertal rise in T in SHR
males, suggesting a possible role of T in the development
of altered vascular reactivity in SHR males [7]. As pre-
viously indicated, however, the role of chronic in vivo T
manipulation in the regulation of mesenteric artery reac-
tivity in the SHR or WKY male is lacking.
Arterial responsiveness to vasoactive factors is also an
important regulator of vascular reactivity. Human studies
have shown that small gluteal arteries from hypertensive
patients have increased sensitivity to vasoconstrictors such
as NE and serotonin [47]. Resistance-sized mesenteric
arteries preincubated with T displayed attenuated vasodi-
lation in response to flutamide, suggesting that T can have
vasoconstrictive effects independent of the AR [48]. Addi-
tionally, research in the A7r5 cell line has demonstrated
that T can suppress calcium entry into cells by inhibition
of L-type calcium channels [28] and can lead to vasocon-
strictive effects by increasing thromboxane, angiotensin II,
endothelin 1 and NE [36]. In small arteries from SHR ani-
mals, CAST + T treatment decreased PE vasoconstriction
compared to CONT and CAST males. Interestingly,
CAST + T treatment in WKY males increased PE-induced
vasoconstriction compared to CONT males. These data
suggest a possible sensitivity and/or functional change in
the adrenergic receptor in SHR and WKY males following
T manipulation. Indeed, the effective concentration
required to constrict the blood vessel to 50% of its initial
diameter was increased in SHR CAST + T males. The
effect of T in WKY animals had the opposite effect,
slightly increasing PE constriction and thereby potentially
decreasing the EC50 value. When this is taken into account
in conjunction with our passive structural data, the
increased wall thickness in SHR CAST +T animals sug-
gests that a relatively minor decrease in vessel diameter of
the vasculature (that is, primary resistance vessels) will
result in overall decreased in blood flow along with
increased systolic blood pressure. This briefly outlined
process is structural autoregulation as described in detail
by Folkow [2].
Another vasoactive factor is plasma NE, which resulted
in decreased PE-induced vasoconstriction in consomic
SHR/y males [4]. A high-sodium diet alone without T
modulation increases plasma NE in both WKY and SHR
[49], and animals fed a high-sodium diet have decreased
plasma NE in SHR males (33%) and WKY males (50%)
after CAST- and T-normalized plasma NE [5]. Taken
together, these findings support the hypothesis that T
and NE contribute to the alteration of resistance vascular
reactivity toward a more hypertensive phenotype. Part of
the difficulty with separating the NE, T and PE data is
the issue of compensation of the vessels in response to
CAST or T replacement. With regard to PE constriction
of resistance-sized mesenteric arteries, the significantly
lowered PE constriction in SHR male rats compared to
WKY rats could imply vascular remodeling or possibly
downregulation of mesenteric artery a-adrenoreceptors.
With regard to vascular remodeling, a decrease in the
initial diameter (caused by increased resting tone or
thicker vascular walls) could therefore result in a poten-
tial decrease in vasoconstriction for the vessel through a
T and/or hemodynamic mechanism, as indicated in our
previous studies [9,50]. Because these structural changes
could potentially lead to significant changes in vessel
pressure, a larger sample size would likely be necessary
to further define this mechanism. An alternative explana-
tion for the reduction in PE responses exhibited by the
mesenteric arteries from the SHR could be the result of
elevated plasma T and NE levels. As both T and NE can
have vascular trophic effects [51,52], alterations in struc-
tural parameters, including an increased wall-to-lumen
ratio, could occur.
Table 4 Passive mechanical parameters from SHR and WKY treatment groups
Treatment Strain CONT CAST CAST + T
Wall stress (dyn/cm
2 ×1 0
3) SHR *3.6 ± 0.3 (n = 9) *4.3 ± 0.4 (n = 12) *3.9 ± 0.5 (n = 10)
WKY 6.9 ± 1.0 (n = 8) 6.2 ± 0.8 (n = 8) 5.9 ± 0.7 (n = 12)
CAST, castrate; CAST + T, castrate plus testosterone; CONT, control; NE, norepinephrine; SHR: spontaneously hypertensive rat; T: testosterone; WKY: Wistar Kyoto.
Data are means ± SEM. All data were collected at 60 mmHg.*= P < 0.05 SHR CONT vs WKY CONT; * = P < 0.05 SHR CAST vs WKY CAST;*= P < 0.05 SHR CAST + T
vs WKY CAST + T.
Toot et al. Biology of Sex Differences 2012, 3:1
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Figure 3 Passive distensibility of resistance-sized mesenteric arteries from spontaneously hypertensive and Wistar Kyoto testosterone-
manipulated males. Data are expressed as percentage distensibility (means ± SEM). (A) Passive distensibility was increased in spontaneously
hypertensive castrate plus testosterone (SHR CAST + T) mesenteric arteries compared to SHR control (SHR CONT) (*P < 0.01) and SHR CAST (*P <
0.01). (B) Passive distensibility was increased in Wistar Kyoto (WKY) CAST mesenteric arteries compared to WKY CONT (*P < 0.05) and WKY CAST
+T( * P < 0.05).
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tial link through which the SHR Y chromosome can
increase sympathetic nervous system activity and adre-
nal TH activity (rate-limiting enzyme of the catechola-
mine pathway), as well as an early rise in prepubertal T,
all of which suggest a possible complex interaction to
yield a hypertensive phenotype in SHR animals [7,14,50].
Both T and NE also exert trophic effects on the vascu-
lar wall [51,52], and T has been shown to alter gene
expression in mesenteric arteries [53]. Work conducted
at our laboratory has also supported the hypothesis that
a relationship of the hydrostatic effect of elevated blood
pressure and an elevated T increases the wall thickness
of blood vessels. For instance, in male SHR from 5 to 15
weeks of age, the final blood pressure and T level
showed a positive correlation with coronary artery
media-to-lumen ratio and coronary collagen [54]. Also,
castration reduced the media thickness by 64%, and T
replacement restored the media thickness [55]. Addi-
tionally, in a normotensive model using WKY males,
territorial stress increased blood pressure by 15 mmHg
and T by 62%, together with a 16% increase in mesen-
teric vessel wall-to-lumen ratio [56]. Furthermore, inves-
tigators at our laboratory have reported that gender
differences in heart disease may result from altered col-
lagen deposition, because mesenteric collagen showed a
twofold increase in males compared to age-matched
females between 4 and 20 weeks of age [7,57]. Interest-
ingly, treatment of left anterior descending fibroblasts
from SHR males with T resulted in a significant increase
in collagen deposition, further suggesting a role for T in
the possible structural regulation of the vessel wall [57].
The findings of this study suggest that resistance-sized
mesenteric artery wall-to-lumen ratios are increased in
SHR males compared to WKY animals, a finding con-
firming the data reported by Mulvany et al. [58] and
Bund [59]. Interestingly, wall stress of resistance-sized
mesenteric arteries is decreased in SHR males compared
to WKY rats, suggesting that thicker vessel walls
decrease circumferential wall tension in SHR males, as
shown by Folkow [2]. Furthermore, passive distensibility
was altered in response to T in SHR males, demonstrat-
ing differences in extracellular matrix components in
SHR mesenteric arteries. This suggests that the active
responses and the structural vessel wall mechanics are
altered in SHR males. This supports the hypothesis that
the mechanism that changes in arterial responsiveness is
related to structural changes in the arterial wall. For
example, the SHR CAST + T males exhibited increased
wall-to-lumen ratios, which could possibly result in less
MYO needed in these arteries to significantly reduced
blood flow and thus, as proposed by Folkow [2], could
have an appreciable effect on systemic blood pressure.
Conclusion
Overall, T replacement in SHR males decreased MYO,
whereas T replacement in WKY males increased MYO
of resistance-sized mesenteric arteries. Similarly to
MYO, PE constriction was decreased in SHR males and
increased in WKY male mesenteric arteries. Addition-
ally, T treatment in SHR males increased wall-to-lumen
ratios and decreased wall stress in mesenteric arteries.
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